MODRA PHARMACEUTICALS

Updated 9 days ago
  • ID: 12689414/119
Barbara Strozzilaan 201 1083 HN Amsterdam The Netherlands
Modra is dedicated to addressing these challenges, and to applying its proprietary approach to improve taxane treatments for these patients. The company's lead program, ModraDoc006/r, is being developed to transform the experience of docetaxel therapy. For the large patient populations that would benefit, this novel oral therapy would be effective in fighting tumors, could be taken at home, and would offer a substantially better safety and tolerability profile... Intravenous (IV) docetaxel and paclitaxel are the most commonly used taxane therapeutics worldwide, prescribed to treat a wide variety of solid tumors. With our pipeline of clinical-stage proprietary boosted oral taxanes, we aim to replace them.
Also known as: Modra, Modra Pharmaceuticals B.V.
Primary location: Amsterdam Netherlands
  • 0
  • 0
Interest Score
1
HIT Score
0.86
Domain
modrapharmaceuticals.com

Actual
modrapharmaceuticals.com

IP
92.205.54.255

Status
OK

Category
Company
0 comments Add a comment